Sucrose

ExcipientCAS 57-50-1UNII C151H8M554

6 organisations hold 6 active FDA Type IV Drug Master Files for Sucrose.

Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity). Methodology

Active Type IV DMFs (6)

HolderDMFFiled asSubmitted
SACCHARON EXCIPIENTS PRIVATE LTD44275SUCROSE USP-NFJun 2026
AGRIZO INDIA40712SUCROSE (IP/BP/USP)Oct 2024
DHANRAJ SUGAR PRIVATE LTD38742SUCROSE USP/BP/IPAug 2023
HUBEI GEDIAN HUMANWELL PHARMACEUTICAL EXCIPIENTS CO LTD
China
36348SUCROSENov 2021
AVT (SHANGHAI) PHARMACEUTICAL TECH CO LTD35209SUCROSE (FOR INJECTION)Sept 2020
MB SUGARS AND PHARMACEUTICALS PRIVATE LTD23812SUCROSE USP NFMay 2010

“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.

What these records establish

  • A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
  • Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
  • The holder is the organisation that filed. It is usually, but not always, the manufacturer.
  • Many excipients are supplied without any DMF, so this list is not every supplier of Sucrose.

How to qualify an excipient supplier

For suppliers

Do you supply Sucrose?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.